Express
Han Yu Pharmaceutical and digital asset platform KuCoin sign strategic cooperation agreement, stock price surges to limit up
Summary: Han Yu Pharmaceutical (300199.SZ) surged to the limit in the afternoon, closing at 24.32 yuan, reaching a new high since December 2022. Han Yu Pharmaceutical and digital asset platform KuCoin have officially signed a strategic cooperation agreement, planning to jointly explore the first RWA tokenization pilot project in mainland China based on 'future revenue rights ...
Han Yu Pharmaceutical (300199.SZ) surged to the limit in the afternoon, closing at 24.32 yuan, reaching a new high since December 2022. Han Yu Pharmaceutical and digital asset platform KuCoin have officially signed a strategic cooperation agreement, planning to jointly explore the first RWA tokenization pilot project in mainland China based on 'future revenue rights of innovative drug research and development' in Hong Kong. According to the agreement, Han Yu Pharmaceutical will use its technical expertise and research pipeline in the GLP-1 peptide heavyweight drug field as the underlying asset, while KuCoin will leverage its advantages in blockchain technology, RWA full-process solutions, and global compliance resources to provide integrated support for the project, including on-chain mapping, asset tokenization, trade matching, and revenue distribution. (Gelonghui)
Tags:
Link: Han Yu Pharmaceutical and digital asset platform KuCoin sign strategic cooperation agreement, stock price surges to limit up [Copy]
